Insulet
PODD
S$383.79
Share price
-0.19%
Change (1 day)
44.34%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Total debt
Total debt on the balance sheet as of March 2025 : S$2.16 Billion
According to Insulet's latest financial reports the company's total debt is S$2.16 Billion. A company’s total debt is the sum of all current and non-current debts.
Insulet - Total debt on balance sheet (from 2005 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$1.89 B | 1.2% |
| 2023-12-31 | S$1.86 B | -0.5% |
| 2022-12-31 | S$1.87 B | 9.12% |
| 2021-12-31 | S$1.72 B | 22.89% |
| 2020-12-31 | S$1.40 B | 17.07% |
| 2019-12-31 | S$1.19 B | 48.01% |
| 2018-12-31 | S$0.80 B | 6.8% |
| 2017-12-31 | S$0.75 B | 57.23% |
| 2016-12-31 | S$0.48 B | 91.83% |
| 2015-12-31 | S$0.25 B | 11.99% |
| 2014-12-31 | S$0.22 B | 45.42% |
| 2013-12-31 | S$0.15 B | 6.69% |
| 2012-12-31 | S$0.14 B | 2.8% |
| 2011-12-31 | S$0.14 B | 57.16% |
| 2010-12-31 | S$89.43 M | -34.31% |
| 2009-12-31 | S$0.13 B | 58.22% |
| 2008-12-31 | S$86.05 M | 124.16% |
| 2007-12-31 | S$38.38 M | -14.33% |
| 2006-12-31 | S$44.8 M | 175.15% |
| 2005-12-31 | S$16.28 M | 90649.52% |
| 2004-12-31 | S$0.01 M | -3.98% |
| 2003-12-31 | S$0.01 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ICU Medical
ICUI | S$2.04 B | -5.60% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | S$0.62 B | -70.91% | 🇺🇸 USA |
 DexCom DXCM | S$3.29 B | 52.37% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$66.61 B | 2,981.99% | 🇺🇸 USA |
 Abbott Laboratories ABT | S$16.88 B | 681.05% | 🇺🇸 USA |
 Medtronic MDT | S$33.91 B | 1,469.36% | 🇮🇪 Ireland |
 Eli Lilly LLY | S$49.10 B | 2,171.79% | 🇺🇸 USA |